Joseph P. Schlessinger

Joseph P.
Schlessinger is the founder of Sugen, Inc. (founded in 1991), Plexxikon, Inc. (founded in 2001), Kolltan Pharmaceuticals, Inc. (founded in 2007), and Inozyme Pharma, Inc. (founded in 2015).
He held the title of Chairman at Plexxikon, Inc. from 2009 to 2010 and Chairman at Inozyme Pharma, Inc. from 2015 to 2020.
Dr. Schlessinger is also the founder of Opna Bio SA. Dr. Schlessinger's current job(s) include Chairman-Pharmacology Department at Yale School of Medicine since 2001, Director-Cancer Biology Institute at Yale University, Member of the Russian Academy of Sciences, Member of the National Academy of Sciences, Member of the National Academy of Medicine (United States), Chief Scientist at Yale Cancer Center, and Member of the European Molecular Biology Organization.
Dr. Schlessinger's former job(s) include Director-Skirball Institute at New York University from 1998 to 2001, Director at StemRad Ltd., and Professor at Weizmann Institute of Science from 1980 to 1991.
Dr. Schlessinger's education history includes undergraduate and graduate degrees from The Hebrew University of Jerusalem and a doctorate degree from Weizmann Institute of Science.